Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Acute Lung Injury

• Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
• An Open-label Study of the Safety and Pharmacokinetics of the TGKP
• To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
• Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
• Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS
• Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
• Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome
• The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
• Inhaled Sevoflurane for ARDS Prevention
• Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
• Vascular ARDS Recruitment After Inhaled Nitric Oxide
• A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
• Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
• Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
• PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
• Sivelestat for Acute Respiratory Distress Syndrome Due to COVID-19
• Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
• Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
• Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Moderate or Severe COVID-19
• 5-HT3 Receptor Antagonist and Respiratory Drive in Patients With ARDS
• Add-on Reparixin in Adult Patients With ARDS
• Study to Verify the Effectiveness and Safety of the Modified Isothymol or Carvacrol Compound Against SARS-CoV-2
• Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model
• Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
• Glucocorticoid Therapy for Acute Respiratory Distress Syndrome
• Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
• Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19
• Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial
• Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium
• Open-Label Single Arm Study to Evaluate Voxelotor for Improving Oxygen Saturation in Adults
• Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
• A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
• Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS
• Nebulised BromAc in Healthy Volunteers
• Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19
• A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms
• Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS
• AVICOVID-3 Inhaled Use of Zyesami for Treatment of Severe COVID-19
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Acute Respiratory Distress Syndrome: A Phase I/II Clinical Trial
• AV-001 for Hospitalized Patients With COVID-19 Disease
• TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
• Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy
• Pirfenidone to Prevent Fibrosis in Ards.
• A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19
• Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection
• A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome
• Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
• Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
• Nigelle 5CH in Prevention of Influanza
• Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial
• Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
• Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19
• Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
• Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
• A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.
• Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury
• In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection
• A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
• Treatment of ARDS With Sivelestat Sodium
• Effect of S-ketamine Anesthetic on Inflammatory Response in Septic Patients Undergoing Abdominal Surgery
• Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
• Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
• Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19
• A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
• Roflumilast in ARDS
• Tolerability and Efficacy of RJX in Patients With COVID-19
• Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19
• A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia
• SILtuximab in Viral ARds (SILVAR) Study
• Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build
• Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
• The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
• An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.
• A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure
• Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
• Trial of Therapeutic Hypothermia in Patients With ARDS
• A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
• Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
• Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection
• Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
• Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
• A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
• Telmisartan in Respiratory Failure Due to COVID-19
• Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)
• Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
• Efficacy and Safety of Itolizumab in COVID-19 Complications
• Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
• VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
• Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
• ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery
• Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
• This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Diffi
• Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
• Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury
• Lessening Organ Dysfunction With VITamin C in Septic ARDS
• TD-0903 for ALI Associated With COVID-19
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
• Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
• Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
• A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
• Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial
• Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
• Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
• The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
• COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
• Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19
• Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome
• A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes
• CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
• MSCs in COVID-19 ARDS
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
• Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19
• Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
• Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19
• Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)
• A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
• First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
• Polyvalent Immunoglobulin in COVID-19 Related ARds
• Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19
• Spironolactone in Covid-19 Induced ARDS
• SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
• Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
• Pre-exposure Prophylaxis for SARS-Coronavirus-2
• Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
• COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
• The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
• Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19
• The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
• Losartan for Patients With COVID-19 Requiring Hospitalization
• Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
• Losartan for Patients With COVID-19 Not Requiring Hospitalization
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
• Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
• Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.
• Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome
• SEvoflurane for Sedation in ARds
• Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients
• Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury
• Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study
• Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
• Sevoflurane PharmacokInetics in ARDS
• Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course
• Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome
• Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery
• Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
• Long Term Outcome on Brain and Lung of Different Oxygen Strategies in ARDS Patients
• Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
• Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS
• Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome
• Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
• N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
• The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium
• A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury
• Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
• Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)
• Study of Renin-angiotensin System in Mechanically Ventilated Subjects
• Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS
• Iloprost in Acute Respiratory Distress Syndrome
• Vitamin D to Improve Outcomes by Leveraging Early Treatment
• Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
• A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome
• Imaging of Peri-operative (periOP) Lung Injury
• Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients
• PGE1 as Additive Anticoagulant in ECMO-Therapy
• The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)
• L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
• Corticosteroid Mediates Acute Respiratory Distress Syndrome
• Liberal Oxygenation Versus Conservative Oxygenation in ARDS
• Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)
• Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia
• Reevaluation Of Systemic Early Neuromuscular Blockade
• Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
• Xenon Against Postoperative Oxygen Impairment
• Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
• Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
• ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial
• Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
• Trial of an Alternate Mode of Providing Artificial Breaths to Children With Very Severe Pneumonia
• Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)
• Safety and Efficacy Study of Acthar in Subjects With ARDS
• Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury
• Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
• Supported Ventilation in ARDS Patients
• Anesthetic Methods and Liver Transplantation
• Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome
• Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection
• Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
• Different Lipid Emulsions in Acute Lung Injury Patients
• LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
• Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
• Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children
• Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome
• Hyperoxia and Hypertonic Saline in Septic Shock
• Safety Study of Inhaled Saline in Acute Lung Injury
• Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury
• The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers
• Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury
• Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma
• Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
• The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
• Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)
• LIPS-A: Lung Injury Prevention Study With Aspirin
• Citrulline in Severe Sepsis
• Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
• Ascorbic Acid (Vitamin C) Infusion in Human Sepsis
• Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome
• Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome
• Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
• Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
• Iloprost Effects on Gas Exchange and Pulmonary Mechanics
• Trial of Steroids in Pediatric Acute Lung Injury/ARDS
• Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS)
• The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)
• Sleep Intervention During Acute Lung Injury
• CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
• SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
• Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
• Statins for Acutely Injured Lungs From Sepsis
• STIP: Statin Trial for Influenza Patients
• Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
• Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS)
• Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
• Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
• Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)
• Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy
• Calfactant for Direct Acute Respiratory Distress Syndrome
• Modulation of Lung Injury Complicating Lung Resection
• Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study
• Hemodynamics and Extravascular Lung Water in Acute Lung Injury
• Early Insulin and Development of ARDS
• Steroids in Patients With Early ARDS
• Prevention of Lung Edema After Thoracic Surgery
• Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
• Drug Study of Albuterol to Treat Acute Lung Injury
• Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
• A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
• Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
• Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
• Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome
• Nitric Oxide Administration for Acute Respiratory Distress Syndrome
• IC14 Antibodies to Treat Individuals With Acute Lung Injury
• Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan
• KL₄Surfactant Treatment in Patients With ARDS
• A Randomized Trial of GM-CSF in Patients With ALI/ARDS
• Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome
• Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
• Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
• Activated Protein C to Treat Acute Lung Injuries
• Carbon Monoxide to Prevent Lung Inflammation
• A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
• Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
• Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
• Ibuprofen in Sepsis Study